Selected research
Industry Research
Enoxaparin Sodium Injection Industry Research Report 2026
Market perspective
The global Enoxaparin Sodium Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Enoxaparin Sodium Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Enoxaparin Sodium Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Enoxaparin Sodium Injection include Teva, Suzhou Erye Pharmaceutical, Sandoz, Sanofi, Nanjing King-friend, Hangzhou Jiuyuan Gene Engineering, Hebei Changshan Biochemical Pharmaceutical, Fresenius Kabi and Changzhou Qianhong Bio-pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Enoxaparin Sodium Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Enoxaparin Sodium Injection Market by Company
Teva
Suzhou Erye Pharmaceutical
Sandoz
Sanofi
Nanjing King-friend
Hangzhou Jiuyuan Gene Engineering
Hebei Changshan Biochemical Pharmaceutical
Fresenius Kabi
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Chengdu Baiyu Pharmaceutical
Techdow (Hepalink)
Taj Pharma
Rovi
Cipla
Apotex
Amphastar
Enoxaparin Sodium Injection Segment by Type
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
20 mg/0.2mL
30 mg/0.3mL
300mg/3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
Enoxaparin Sodium Injection Segment by Application
Hospital
Clinic
Others
Enoxaparin Sodium Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Enoxaparin Sodium Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Enoxaparin Sodium Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Enoxaparin Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100 mg/1mL
- 120 mg/0.8mL
- 150 mg/1mL
- 20 mg/0.2mL
- 30 mg/0.3mL
- 300mg/3mL
- 40 mg/0.4mL
- 60 mg/0.6mL
- 80 mg/0.8mL
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva
- Suzhou Erye Pharmaceutical
- Sandoz
- Sanofi
- Nanjing King-friend
- Hangzhou Jiuyuan Gene Engineering
- Hebei Changshan Biochemical Pharmaceutical
- Fresenius Kabi
- Changzhou Qianhong Bio-pharma
- Beijing SL Pharmaceutical
- Chengdu Baiyu Pharmaceutical
- Techdow (Hepalink)
- Taj Pharma
- Rovi
- Cipla
- Apotex
- Amphastar
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Enoxaparin Sodium Injection Market Size (2021-2032)
- 2.2.2 Global Enoxaparin Sodium Injection Sales (2021-2032)
- 2.2.3 Global Enoxaparin Sodium Injection Market Average Price (2021-2032)
- 2.3 Enoxaparin Sodium Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 100 mg/1mL
- 2.3.3 120 mg/0.8mL
- 2.3.4 150 mg/1mL
- 2.3.5 20 mg/0.2mL
- 2.3.6 30 mg/0.3mL
- 2.3.7 300mg/3mL
- 2.3.8 40 mg/0.4mL
- 2.3.9 60 mg/0.6mL
- 2.3.10 80 mg/0.8mL
- 2.4 Enoxaparin Sodium Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Enoxaparin Sodium Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Enoxaparin Sodium Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Enoxaparin Sodium Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Enoxaparin Sodium Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Enoxaparin Sodium Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Enoxaparin Sodium Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Enoxaparin Sodium Injection, Product Type & Application
- 3.8 Global Manufacturers of Enoxaparin Sodium Injection, Established Date
- 3.9 Global Enoxaparin Sodium Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Enoxaparin Sodium Injection Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Suzhou Erye Pharmaceutical
- 4.2.1 Suzhou Erye Pharmaceutical Company Information
- 4.2.2 Suzhou Erye Pharmaceutical Business Overview
- 4.2.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
- 4.2.5 Suzhou Erye Pharmaceutical Recent Developments
- 4.3 Sandoz
- 4.3.1 Sandoz Company Information
- 4.3.2 Sandoz Business Overview
- 4.3.3 Sandoz Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sandoz Enoxaparin Sodium Injection Product Portfolio
- 4.3.5 Sandoz Recent Developments
- 4.4 Sanofi
- 4.4.1 Sanofi Company Information
- 4.4.2 Sanofi Business Overview
- 4.4.3 Sanofi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi Enoxaparin Sodium Injection Product Portfolio
- 4.4.5 Sanofi Recent Developments
- 4.5 Nanjing King-friend
- 4.5.1 Nanjing King-friend Company Information
- 4.5.2 Nanjing King-friend Business Overview
- 4.5.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio
- 4.5.5 Nanjing King-friend Recent Developments
- 4.6 Hangzhou Jiuyuan Gene Engineering
- 4.6.1 Hangzhou Jiuyuan Gene Engineering Company Information
- 4.6.2 Hangzhou Jiuyuan Gene Engineering Business Overview
- 4.6.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio
- 4.6.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
- 4.7 Hebei Changshan Biochemical Pharmaceutical
- 4.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
- 4.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
- 4.7.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
- 4.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
- 4.8 Fresenius Kabi
- 4.8.1 Fresenius Kabi Company Information
- 4.8.2 Fresenius Kabi Business Overview
- 4.8.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio
- 4.8.5 Fresenius Kabi Recent Developments
- 4.9 Changzhou Qianhong Bio-pharma
- 4.9.1 Changzhou Qianhong Bio-pharma Company Information
- 4.9.2 Changzhou Qianhong Bio-pharma Business Overview
- 4.9.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio
- 4.9.5 Changzhou Qianhong Bio-pharma Recent Developments
- 4.10 Beijing SL Pharmaceutical
- 4.10.1 Beijing SL Pharmaceutical Company Information
- 4.10.2 Beijing SL Pharmaceutical Business Overview
- 4.10.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
- 4.10.5 Beijing SL Pharmaceutical Recent Developments
- 4.11 Chengdu Baiyu Pharmaceutical
- 4.11.1 Chengdu Baiyu Pharmaceutical Company Information
- 4.11.2 Chengdu Baiyu Pharmaceutical Business Overview
- 4.11.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
- 4.11.5 Chengdu Baiyu Pharmaceutical Recent Developments
- 4.12 Techdow (Hepalink)
- 4.12.1 Techdow (Hepalink) Company Information
- 4.12.2 Techdow (Hepalink) Business Overview
- 4.12.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio
- 4.12.5 Techdow (Hepalink) Recent Developments
- 4.13 Taj Pharma
- 4.13.1 Taj Pharma Company Information
- 4.13.2 Taj Pharma Business Overview
- 4.13.3 Taj Pharma Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Taj Pharma Enoxaparin Sodium Injection Product Portfolio
- 4.13.5 Taj Pharma Recent Developments
- 4.14 Rovi
- 4.14.1 Rovi Company Information
- 4.14.2 Rovi Business Overview
- 4.14.3 Rovi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Rovi Enoxaparin Sodium Injection Product Portfolio
- 4.14.5 Rovi Recent Developments
- 4.15 Cipla
- 4.15.1 Cipla Company Information
- 4.15.2 Cipla Business Overview
- 4.15.3 Cipla Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Cipla Enoxaparin Sodium Injection Product Portfolio
- 4.15.5 Cipla Recent Developments
- 4.16 Apotex
- 4.16.1 Apotex Company Information
- 4.16.2 Apotex Business Overview
- 4.16.3 Apotex Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Apotex Enoxaparin Sodium Injection Product Portfolio
- 4.16.5 Apotex Recent Developments
- 4.17 Amphastar
- 4.17.1 Amphastar Company Information
- 4.17.2 Amphastar Business Overview
- 4.17.3 Amphastar Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Amphastar Enoxaparin Sodium Injection Product Portfolio
- 4.17.5 Amphastar Recent Developments
5 Global Enoxaparin Sodium Injection Market Scenario by Region
- 5.1 Global Enoxaparin Sodium Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Enoxaparin Sodium Injection Sales by Region: 2021-2032
- 5.2.1 Global Enoxaparin Sodium Injection Sales by Region: 2021-2026
- 5.2.2 Global Enoxaparin Sodium Injection Sales by Region: 2027-2032
- 5.3 Global Enoxaparin Sodium Injection Revenue by Region: 2021-2032
- 5.3.1 Global Enoxaparin Sodium Injection Revenue by Region: 2021-2026
- 5.3.2 Global Enoxaparin Sodium Injection Revenue by Region: 2027-2032
- 5.4 North America Enoxaparin Sodium Injection Market Facts & Figures by Country
- 5.4.1 North America Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Enoxaparin Sodium Injection Sales by Country (2021-2032)
- 5.4.3 North America Enoxaparin Sodium Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Enoxaparin Sodium Injection Market Facts & Figures by Country
- 5.5.1 Europe Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Enoxaparin Sodium Injection Sales by Country (2021-2032)
- 5.5.3 Europe Enoxaparin Sodium Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Enoxaparin Sodium Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Enoxaparin Sodium Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Enoxaparin Sodium Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Enoxaparin Sodium Injection Market Facts & Figures by Country
- 5.7.1 South America Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Enoxaparin Sodium Injection Sales by Country (2021-2032)
- 5.7.3 South America Enoxaparin Sodium Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Enoxaparin Sodium Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Enoxaparin Sodium Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Enoxaparin Sodium Injection Sales by Type (2021-2032)
- 6.1.1 Global Enoxaparin Sodium Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Enoxaparin Sodium Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Enoxaparin Sodium Injection Revenue by Type (2021-2032)
- 6.2.1 Global Enoxaparin Sodium Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Enoxaparin Sodium Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Enoxaparin Sodium Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Enoxaparin Sodium Injection Sales by Application (2021-2032)
- 7.1.1 Global Enoxaparin Sodium Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Enoxaparin Sodium Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Enoxaparin Sodium Injection Revenue by Application (2021-2032)
- 7.2.1 Global Enoxaparin Sodium Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Enoxaparin Sodium Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Enoxaparin Sodium Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Enoxaparin Sodium Injection Value Chain Analysis
- 8.1.1 Enoxaparin Sodium Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Enoxaparin Sodium Injection Production Mode & Process
- 8.2 Enoxaparin Sodium Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Enoxaparin Sodium Injection Distributors
- 8.2.3 Enoxaparin Sodium Injection Customers
9 Global Enoxaparin Sodium Injection Analyzing Market Dynamics
- 9.1 Enoxaparin Sodium Injection Industry Trends
- 9.2 Enoxaparin Sodium Injection Industry Drivers
- 9.3 Enoxaparin Sodium Injection Industry Opportunities and Challenges
- 9.4 Enoxaparin Sodium Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst